Unimad Pharmaceuticals Pvt Ltd
About Unimad Pharmaceuticals Pvt Ltd
Data last updated:
Unimad Pharmaceuticals Pvt Ltd is a private limited company based in Ludhiana, Punjab, India. It operates in the chemical products segment of the chemicals sector. It was incorporated on 19 January 1983 and has been in existence for over 43 years.
The company is registered with the Registrar of Companies (ROC), Chandigarh, under CIN U24232PB1983PTC005268.
The company has an authorised share capital of ₹5 Lakh and a paid-up capital of ₹2.97 Lakh. It is led by directors including Babar Kailay and Jitender Singh.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at Barewal Laneferozpur Road Ludhiana, Punjab, India – 141001.
As per the financials filed for FY 2024, the company reported a revenue of ₹20.46 Lakh, reflecting significant growth compared to the previous year. For the same year it recorded a net profit of ₹3.32 Lakh (net margin 16.2%) and EBITDA of ₹4.03 Lakh (EBITDA margin 19.7%). Revenue has declined at a compounded annual rate (CAGR) of 52% over three years and 3% over five years.
As per MCA filings, the company has open charges of ₹70,000 on record.
The current compliance status is marked as compliant by the Registrar of Companies.
- EmailLocked
- TelephoneLocked
- WebsiteLocked
- Social MediaLocked
- Registered AddressBarewal Laneferozpur Road Ludhiana, Punjab, India – 141001
- IndustryChemicals, Chemical Products, Medicinal Chemical & Botanical Products, Pharmaceuticals
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
- One PDF report, delivered after checkout
Business Activity of Unimad Pharmaceuticals Pvt Ltd
The main business activity of Unimad Pharmaceuticals is manufacturing. In detail, this covers chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products.
| Main Activity Group Code | Description of Main Activity | Business Activity Code | Description of Business Activity | Turnover Percentage |
|---|---|---|---|---|
| C | Manufacturing | C6 | Chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products | Locked |
Business activity turnover details
Turnover share and past changes in activity are in the company report.
- Turnover contribution
- Historical classifications
- Filing-level activity changes
Verified entity values are shown only after access is granted.
Financials of Unimad Pharmaceuticals Pvt Ltd FY 2025 filings available
Unimad Pharmaceuticals Pvt Ltd reported revenue of ₹20.46 Lakh (up 538% YoY) for FY 2024.
Compounded Annual Growth Rate (CAGR) of Unimad Pharmaceuticals Pvt Ltd
Revenue rose 538% in the latest year, though over five years it has declined at a compounded annual rate (CAGR) of 3%. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary of Unimad Pharmaceuticals Pvt Ltd
| Metrics | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | •••• | •••• | •••• | •••• | •••• |
| Other Income | •••• | •••• | •••• | •••• | •••• |
| Total Revenue | •••• | •••• | •••• | •••• | •••• |
| Cost of Materials Consumed | •••• | •••• | •••• | •••• | •••• |
| Employee Benefit Expense | •••• | •••• | •••• | •••• | •••• |
| Finance Costs | •••• | •••• | •••• | •••• | •••• |
| Depreciation and Amortisation | •••• | •••• | •••• | •••• | •••• |
| Other Expenses | •••• | •••• | •••• | •••• | •••• |
| Total Expenses | •••• | •••• | •••• | •••• | •••• |
| EBITDA | ₹4.03 Lakh | •••• | •••• | •••• | •••• |
| Profit Before Tax | •••• | •••• | •••• | •••• | •••• |
| Tax Expense | •••• | •••• | •••• | •••• | •••• |
| Net Profit (PAT) | ₹3.32 Lakh | •••• | •••• | •••• | •••• |
| Balance Sheet | |||||
| Share Capital | •••• | •••• | •••• | •••• | •••• |
| Reserves and Surplus | •••• | •••• | •••• | •••• | •••• |
| Net Worth (Total Equity) | •••• | •••• | •••• | •••• | •••• |
| Long-term Borrowings | •••• | •••• | •••• | •••• | •••• |
| Short-term Borrowings | •••• | •••• | •••• | •••• | •••• |
| Trade Payables | •••• | •••• | •••• | •••• | •••• |
| Total Liabilities | •••• | •••• | •••• | •••• | •••• |
| Fixed Assets | •••• | •••• | •••• | •••• | •••• |
| Investments | •••• | •••• | •••• | •••• | •••• |
| Inventories | •••• | •••• | •••• | •••• | •••• |
| Trade Receivables | •••• | •••• | •••• | •••• | •••• |
| Cash and Bank Balance | •••• | •••• | •••• | •••• | •••• |
| Total Assets | •••• | •••• | •••• | •••• | •••• |
Financial Ratios of Unimad Pharmaceuticals Pvt Ltd
| Metrics | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 19.7% | •••• | •••• | •••• | •••• |
| Net Profit Margin | 16.2% | •••• | •••• | •••• | •••• |
| Return on Equity (ROE) | •••• | •••• | •••• | •••• | •••• |
| Return on Capital Employed (ROCE) | •••• | •••• | •••• | •••• | •••• |
| Return on Assets (ROA) | •••• | •••• | •••• | •••• | •••• |
| Liquidity and Debt | |||||
| Current Ratio | •••• | •••• | •••• | •••• | •••• |
| Quick Ratio | •••• | •••• | •••• | •••• | •••• |
| Debt-to-Equity Ratio | •••• | •••• | •••• | •••• | •••• |
| Interest Coverage Ratio | •••• | •••• | •••• | •••• | •••• |
| Efficiency and Growth | |||||
| Asset Turnover | •••• | •••• | •••• | •••• | •••• |
| Receivable Days | •••• | •••• | •••• | •••• | •••• |
| Payable Days | •••• | •••• | •••• | •••• | •••• |
| Inventory Days | •••• | •••• | •••• | •••• | •••• |
| Revenue Growth | •••• | •••• | •••• | •••• | •••• |
| Net Profit Growth | •••• | •••• | •••• | •••• | •••• |
Paid data: the figures shown as dots are available after purchase of the company report. Figures as filed with the MCA in Form AOC-4. The full year-wise statements and ratios of Unimad Pharmaceuticals are in the company report.
Financial statements from 2015
Earlier years and trend charts are in the company report.
- Income statements
- Balance sheets
- Cash-flow statements
- Ratios and benchmarks
Verified entity values are shown only after access is granted.
Peer Comparison of Unimad Pharmaceuticals Pvt Ltd
Unimad Pharmaceuticals Pvt Ltd is compared with the companies closest to it by revenue in the Pharma industry (Pharmaceuticals). Net profit, margin and employee counts of each company are in the company report.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Confiado Pharmaceuticals Private Limited | ₹20.56 Lakh (FY 2025) | •••• | •••• | 19.0% | •••• | Kannankulangara, Kerala, India |
| Healthwealth Pharmaceuticals Private Limited | ₹20.54 Lakh (FY 2017) | •••• | •••• | -75.0% | •••• | Chennai, Tamil Nadu, India |
| Sankalp Pharmaceuticals Private Limited | ₹20.51 Lakh (FY 2016) | •••• | •••• | 12.0% | •••• | Bhojpur, Bihar, India |
| Bahisht Pharmaceuticals Private Limited | ₹20.49 Lakh (FY 2025) | •••• | •••• | 370.0% | •••• | Srinagar, Jammu and Kashmir, India |
| Arcon Pharmaceuticals Private Limited | ₹20.48 Lakh (FY 2025) | •••• | •••• | -22.0% | •••• | Patna, Bihar, India |
| Unimad Pharmaceuticals Pvt Ltd this company | ₹20.46 Lakh (FY 2024) | •••• | •••• | 538.0% | •••• | Ludhiana, Punjab, India |
| Powercure Pharmaceuticals Private Limited | ₹20.46 Lakh (FY 2016) | •••• | •••• | 1101.0% | •••• | Yelahanka, Karnataka, India |
| Keyares Pharmaceuticals Private Limited | ₹20.42 Lakh (FY 2022) | •••• | •••• | •••• | Patna, Bihar, India | |
| Descant Pharmaceuticals Private Limited | ₹20.41 Lakh (FY 2024) | •••• | •••• | -18.0% | •••• | Unnao, Uttar Pradesh, India |
| Nanobot Pharmaceuticals Private Limited | ₹20.4 Lakh (FY 2025) | •••• | •••• | 24.0% | •••• | Pune, Maharashtra, India |
| Starmet Pharmaceuticals Private Limited | ₹20.38 Lakh (FY 2024) | •••• | •••• | -14.0% | •••• | Mirzapur, Uttar Pradesh, India |
Peers are the five companies nearest above and the five nearest below Unimad Pharmaceuticals by revenue in the Pharma industry (Pharmaceuticals), from the latest filed financials of each company. Net profit, margin and employee counts of each peer are in the company report.
Auditor Details of Unimad Pharmaceuticals Pvt Ltd
Unimad Pharmaceuticals Pvt Ltd is audited by RAJ GUPTA & CO. for the financial year 2017.
| Name | Status | Appointment Date | Cessation Date |
|---|---|---|---|
| RAJ GUPTA & CO. | Locked | Locked | Locked |
Complete auditor history
Appointment and cessation dates and past auditor changes are in the company report.
- Appointment status
- Appointment dates
- Cessation dates
- Auditor changes
Verified entity values are shown only after access is granted.
Board of Directors of Unimad Pharmaceuticals Pvt Ltd
Unimad Pharmaceuticals has 3 current directors and 1 former director. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Babar Kailay | Director | 09 Dec 2023 | 2 Years 10 Months | Current |
| Jitender Singh | Director | 20 Apr 1992 | 34 Years 5 Months | Current |
| Jagjit Singh | Director | 12 Jun 1991 | 35 Years 3 Months | Current |
Ownership and Shareholding of Unimad Pharmaceuticals Pvt Ltd
Shareholding and ownership data
Promoter, institutional, public and beneficial ownership figures are in the company report.
- Ownership categories
- Historical changes
- Group structure
- FII and DII holdings
Verified entity values are shown only after access is granted.
Charges & Borrowings of Unimad Pharmaceuticals Pvt Ltd
| Date | Lender | Amount | Status |
|---|---|---|---|
| 30 Jul 1983 | State Bank of Patiala | ₹70,000 | Open |
Total charge records: 1 View all charges
Employees and EPFO Compliance at Unimad Pharmaceuticals Pvt Ltd
Employment history and EPFO contributions of people linked to Unimad Pharmaceuticals.
Employee and EPFO history
Monthly headcount, contribution history and filing status are in the company report.
- Monthly headcount
- PF contributions
- ECR filing status
- Establishment history
Verified entity values are shown only after access is granted.
Recent Activity on Unimad Pharmaceuticals Pvt Ltd
Unimad Pharmaceuticals Pvt Ltd has 5 board changes on record since 1991: 4 appointments and 1 cessation. The latest: Ujagar Singh ceased to be Director on 15 Mar 2025.
Credit Ratings, Litigation & Regulatory Alerts for Unimad Pharmaceuticals Pvt Ltd
Credit ratings, litigation, and regulatory alerts
Credit ratings, court records and regulatory alerts are in the company report.
- Rating history
- Court and tribunal cases
- Regulatory alerts
- Director-linked violations
Verified entity values are shown only after access is granted.
MSME Payment Delays by Unimad Pharmaceuticals Pvt Ltd
MSME payment history
Amounts due to small suppliers, the reasons given and MSME-1 filings are in the company report.
- Outstanding amounts
- Delay periods and reasons
- MSME-1 filing history
- Vendor payment signals
Verified entity values are shown only after access is granted.
Subsidiaries & Group Companies of Unimad Pharmaceuticals Pvt Ltd
Corporate group structure
Parent, subsidiary, associate and joint venture records with holdings are in the company report.
- Parent company
- Subsidiaries and ownership
- Associates and joint ventures
- Entity investments
Verified entity values are shown only after access is granted.
GST Compliance of Unimad Pharmaceuticals Pvt Ltd
GST registrations and filing compliance
State-wise GST registrations, return filing status and HSN or SAC codes are in the company report.
- GSTIN registrations
- State-wise filing status
- HSN and SAC details
- Tax jurisdiction records
Verified entity values are shown only after access is granted.
MCA Filings & Documents of Unimad Pharmaceuticals Pvt Ltd
MCA filings and documents
Filed forms, annual returns, financial statements and charge filings with their dates are in the company report.
- Incorporation documents
- Annual returns and statements
- Charge filings
- Complete filing index
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Unimad Pharmaceuticals Pvt Ltd
Unimad Pharmaceuticals is an active private limited company based in Ludhiana, Punjab, India. The company works in chemical products, within the chemicals industry. It was incorporated on 19 January 1983 (43+ years old) and is registered under CIN U24232PB1983PTC005268.
Unimad Pharmaceuticals reported revenue of ₹20.46 Lakh for FY 2024 (up 538% YoY).
Unimad Pharmaceuticals has 3 current directors:
- Babar Kailay - Director
- Jitender Singh - Director
- Jagjit Singh - Director
Unimad Pharmaceuticals reported a net profit of ₹3.32 Lakh (net margin 16.2%) and EBITDA of ₹4.03 Lakh (EBITDA margin 19.7%) for FY 2024, as per its filed financial statements.
The compounded annual growth rate (CAGR) of the revenue of Unimad Pharmaceuticals is 52% over three years and -3% over five years. In the latest year (FY 2024) revenue rose 538%. CAGR is the steady yearly rate that links the first and the last year.
The CIN (Corporate Identification Number) of Unimad Pharmaceuticals is U24232PB1983PTC005268. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Unimad Pharmaceuticals was incorporated on 19 January 1983, making it 43+ years old. It is registered with the Registrar of Companies, Chandigarh.
The peers of Unimad Pharmaceuticals by revenue are Confiado Pharmaceuticals Private Limited, Healthwealth Pharmaceuticals Private Limited, Sankalp Pharmaceuticals Private Limited, Bahisht Pharmaceuticals Private Limited, Arcon Pharmaceuticals Private Limited and 5 more, all in the Pharma industry (Pharmaceuticals).
Ujagar Singh ceased to be Director on 15 Mar 2025. Babar Kailay was appointed as Director on 09 Dec 2023. Jitender Singh was appointed as Director on 20 Apr 1992. Unimad Pharmaceuticals has 5 board changes on record in total.
The registered office of Unimad Pharmaceuticals is at Barewal Laneferozpur Road Ludhiana, Punjab, India – 141001.
Unimad Pharmaceuticals has an authorised share capital of ₹5 Lakh and a paid-up capital of ₹2.97 Lakh.